The future of extracorporeal support - PubMed

Review

The future of extracorporeal support

Dinna Cruz et al. Crit Care Med. 2008 Apr.

Abstract

Extracorporeal therapy has expanded significantly over the past few decades from solely artificial renal replacement therapy. In patients with multiple organ dysfunction syndrome, it becomes necessary to provide multiple organ support therapy. Technological advances have opened the door to a multifaceted intervention directed at supporting the function of multiple organs through the treatment of blood. Indications for "old" therapies such as hemofiltration and adsorption have been expanded, and using these therapies in combination further enhances blood detoxification capabilities. Furthermore, new devices are constantly in development. Nanotechnology allows us to refine membrane characteristics and design innovative monitoring/biofeedback devices. Miniaturization is leading down the path of wearable/implantable devices. With the incorporation of viable cells within medical devices, these instruments become capable not only of detoxification but synthetic functions as well, bringing us closer to the holy grail of complete replacement of organ function. This article provides a brief overview of current and future direction in extracorporeal support in the critical care setting.

Similar articles

• Acute renal failure in critically ill patients: indications for and choice of extracorporeal treatment.

  Formica M, Inguaggiato P, Bainotti S, Gigliola G, Canepari G. Formica M, et al. J Nephrol. 2007 Jan-Feb;20(1):15-20. J Nephrol. 2007. PMID: 17347968 Review.

• Recent evolution of renal replacement therapy in the critically ill patient.

  Ronco C. Ronco C. Crit Care. 2006 Feb;10(1):123. doi: 10.1186/cc4843. Crit Care. 2006. PMID: 16542480 Free PMC article. Review.

• [Renal replacement therapy by hemodialysis: an overview].

  Jacobs C. Jacobs C. Nephrol Ther. 2009 Jul;5(4):306-12. doi: 10.1016/j.nephro.2009.03.001. Epub 2009 May 28. Nephrol Ther. 2009. PMID: 19481513 Review. French.

• Beyond dialysis: current and emerging blood purification techniques.

  Stegmayr B, Ramlow W, Balogun RA. Stegmayr B, et al. Semin Dial. 2012 Mar-Apr;25(2):207-13. doi: 10.1111/j.1525-139X.2011.01034.x. Semin Dial. 2012. PMID: 22428812

• Artificial organs, quo vadis?

  Nosé Y. Nosé Y. Artif Organs. 1997 May;21(5):347-8. Artif Organs. 1997. PMID: 9129763 No abstract available.

Cited by

• Advances in hemodialysis therapy.

  Thajudeen B, Issa D, Roy-Chaudhury P. Thajudeen B, et al. Fac Rev. 2023 May 16;12:12. doi: 10.12703/r/12-12. eCollection 2023. Fac Rev. 2023. PMID: 37284495 Free PMC article. Review.

• The future of critical care: renal support in 2027.

  Clark WR, Neri M, Garzotto F, Ricci Z, Goldstein SL, Ding X, Xu J, Ronco C. Clark WR, et al. Crit Care. 2017 Apr 11;21(1):92. doi: 10.1186/s13054-017-1665-6. Crit Care. 2017. PMID: 28395664 Free PMC article. Review.

• Protective effect of resin adsorption on septic plasma-induced tubular injury.

  Cantaluppi V, Weber V, Lauritano C, Figliolini F, Beltramo S, Biancone L, De Cal M, Cruz D, Ronco C, Segoloni GP, Tetta C, Camussi G. Cantaluppi V, et al. Crit Care. 2010;14(1):R4. doi: 10.1186/cc8835. Epub 2010 Jan 11. Crit Care. 2010. PMID: 20064258 Free PMC article.

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Wolters Kluwer

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Miscellaneous

  • NCI CPTAC Assay Portal